Young sub-Saharan women are a group that is vulnerable to the sexual transmission of HIV. Pre-exposure prophylaxis through vaginal microbicides could provide them an option for self-protection. Dapivirine has been demonstrated to have topical inhibitory effects in HIV, and to provide protection against the sexual transmission of this virus. This paper reports on the studies into swelling behaviour, bioadhesion and release carried out on dapivirine tablets based on chitosan, locust bean gum and pectin, to select the most suitable formulation. The modified simulated vaginal fluid led to a high solubility of dapivirine and allowed the dapivirine release profiles to be characterized in sink conditions; this aqueous medium is an alternative to o...
HIV is one of the most serious health issues in the world. Women are disproportionally affected by s...
Vaginal microbicides have the potential to give women at high risk of contracting HIV the option of ...
Background: HIV infection has been a global health issue for past three decades. Around 2 million ne...
Young sub-Saharan women are a group that is vulnerable to the sexual transmission of HIV. Pre-exposu...
Young sub-Saharan women are a group that is vulnerable to the sexual transmission of HIV. Pre-exposu...
Sub-Saharan African women are still at risk from the human immunodeficiency virus (HIV), and sex wit...
The HIV epidemic is an ongoing global health challenge. Prevention strategies are one means to comba...
The HIV epidemic is an ongoing global health challenge. Prevention strategies are one means to comba...
Sub-Saharan African women are still at risk from the human immunodeficiency virus (HIV), and sex wit...
ABSTRACT: The HIV-1 replication inhibitor dapivirine (DPV) is one of the most promising drug candida...
The main challenges facing efforts to prevent the transmission of human immunodeficiency virus (HIV)...
The main challenges facing efforts to prevent the transmission of human immunodeficiency virus (HIV)...
The main challenges facing efforts to prevent the transmission of human immunodeficiency virus (HIV)...
The human immunodeficiency virus (HIV) is a global health pandemic and over 70% of those living with...
Novel in vitro and in vivo model systems to study intravaginal microbicide uptakeAnti-HIV microbicid...
HIV is one of the most serious health issues in the world. Women are disproportionally affected by s...
Vaginal microbicides have the potential to give women at high risk of contracting HIV the option of ...
Background: HIV infection has been a global health issue for past three decades. Around 2 million ne...
Young sub-Saharan women are a group that is vulnerable to the sexual transmission of HIV. Pre-exposu...
Young sub-Saharan women are a group that is vulnerable to the sexual transmission of HIV. Pre-exposu...
Sub-Saharan African women are still at risk from the human immunodeficiency virus (HIV), and sex wit...
The HIV epidemic is an ongoing global health challenge. Prevention strategies are one means to comba...
The HIV epidemic is an ongoing global health challenge. Prevention strategies are one means to comba...
Sub-Saharan African women are still at risk from the human immunodeficiency virus (HIV), and sex wit...
ABSTRACT: The HIV-1 replication inhibitor dapivirine (DPV) is one of the most promising drug candida...
The main challenges facing efforts to prevent the transmission of human immunodeficiency virus (HIV)...
The main challenges facing efforts to prevent the transmission of human immunodeficiency virus (HIV)...
The main challenges facing efforts to prevent the transmission of human immunodeficiency virus (HIV)...
The human immunodeficiency virus (HIV) is a global health pandemic and over 70% of those living with...
Novel in vitro and in vivo model systems to study intravaginal microbicide uptakeAnti-HIV microbicid...
HIV is one of the most serious health issues in the world. Women are disproportionally affected by s...
Vaginal microbicides have the potential to give women at high risk of contracting HIV the option of ...
Background: HIV infection has been a global health issue for past three decades. Around 2 million ne...